How anti-COVID-19 Sputnik V vaccine produced in Kazakhstan

рус | en

How anti-COVID-19 Sputnik V vaccine produced in Kazakhstan

How anti-COVID-19 Sputnik V vaccine produced in Kazakhstan

Photo courtesy of the source

A press tour to the production area of Karaganda Pharmaceutical Complex LLP took place, during which the General Director of LLP Sergey Baron, as well as the Deputy Chairman of the Committee for Medical and Pharmaceutical Control of the Ministry of Health of the Republic of Kazakhstan Nurlybek Asylbekov demonstrated the production process of the Russian vaccine against coronavirus infection Sputnik V to the journalists, reports with reference to the press service of the Ministry of Health.

On December 13, Karaganda Pharmaceutical Complex LLP received a substance for production of a pilot batch of the drug in the amount of 6 thousand doses.

"Together with the working group of the Ministry of Health of the Republic of Kazakhstan, partners from RDIF and Generium developed a roadmap; all issues are discussed on a daily basis. We have carried out technology transfer, production preparation, retrofitting with refrigeration equipment and personnel training in a short time. The release of a pilot series of vaccines for the study of its quality and registration in Kazakhstan has started", - noted S. Baron.

From December 24, 2020 to January 21, 2021, the vaccine will undergo quality control at the National Research Center for Epidemiology and Microbiology named after N.F. Gamalei. In case of successful testing from January 26 to February 11, 2021, it is planned to register the drug in the Republic of Kazakhstan.

"We plan to complete the registration of the vaccine produced at our site and transfer the first batch to the RDIF by February 12, 2021. The owner and supplier of the vaccine of SK-Pharmacy LLP is the Russian Direct Investment Fund," S. Baron emphasized.

It is expected that in February 2021, 80 thousand doses of the Sputnik V vaccine will be produced, in March - 150 thousand doses, and from April the volumes will be increased to 600 thousand doses.

"At the initial stage, it is planned to vaccinate medical workers, including the personnel of infectious diseases hospitals and emergency medical care, as well as teachers who, by the nature of their professional activities, are subject to a high risk of infection," N. Asylbekov said.

According to preliminary data, for immunization of 20% of the population, at least 6 million doses are needed, for 50% of the population - up to 20 million doses, taking into account a two-fold immunization schedule. The final data on the need for the vaccine is being formed. Currently, the Ministry of Health is working to prepare a vaccination plan against COVID-19. Vaccination against CVI will be organized on the basis of the existing vaccination rooms of medical organizations conducting routine preventive vaccinations.

During the press tour, journalists got acquainted with the vaccine production process, visited the workshops for injectable and lyophilized drugs, the labeling line, secondary packaging and storage of the vaccine.

14:20, 22 December 2020

sourse of information:

Go Back

Leave a comment